Literature DB >> 15313559

Fluorescence-based assays for RGS box function.

Francis S Willard1, Randall J Kimple, Adam J Kimple, Christopher A Johnston, David P Siderovski.   

Abstract

Ligand-activated, seven transmembrane-spanning receptors interact with inactive G-protein heterotrimers (Galphabetagamma) to catalyze GTP loading and, consequently, activation of Galpha subunits and the liberation of Gbetagamma. Galpha.GTP and Gbetagamma are then competent to regulate independent effector pathways. The duration of heterotrimeric G-protein signaling is determined by the lifetime of the Galpha subunit in the GTP-bound state. Signal termination is facilitated by the intrinsic guanosine triphosphatase (GTPase) activity of Galpha and subsequent reformation of the inactive heterotrimer. Regulators of G-protein signaling (RGS) proteins act enzymatically, via their hallmark "RGS box," as GTPase-accelerating proteins (GAPs) for Galpha subunits and thus function as negative regulators of G-protein signaling in vitro and in vivo. This article describes the use of fluorescence resonance energy transfer (FRET) to monitor the interaction between a Galpha subunit and an RGS box protein. Furthermore, this article describes optimization of this assay for high-throughput screening and the evaluation of mutant RGS box and Galpha proteins. Finally, this article describes the novel application of this FRET technique to measure the activity of RGS protein-derived GoLoco peptides that modulate Galpha activation by aluminum tetrafluoride.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313559     DOI: 10.1016/S0076-6879(04)89004-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  11 in total

1.  Evaluating modulators of "Regulator of G-protein Signaling" (RGS) proteins.

Authors:  Dustin E Bosch; Thomas Zielinski; Robert G Lowery; David P Siderovski
Journal:  Curr Protoc Pharmacol       Date:  2012-03

2.  Structure of Galpha(i1) bound to a GDP-selective peptide provides insight into guanine nucleotide exchange.

Authors:  Christopher A Johnston; Francis S Willard; Mark R Jezyk; Zoey Fredericks; Erik T Bodor; Miller B Jones; Rainer Blaesius; Val J Watts; T Kendall Harden; John Sondek; J Kevin Ramer; David P Siderovski
Journal:  Structure       Date:  2005-07       Impact factor: 5.006

3.  Minimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimer.

Authors:  Christopher A Johnston; Ekaterina S Lobanova; Alexander S Shavkunov; Justin Low; J Kevin Ramer; Rainer Blaesius; Zoey Fredericks; Francis S Willard; Brian Kuhlman; Vadim Y Arshavsky; David P Siderovski
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

4.  Structural determinants of G-protein alpha subunit selectivity by regulator of G-protein signaling 2 (RGS2).

Authors:  Adam J Kimple; Meera Soundararajan; Stephanie Q Hutsell; Annette K Roos; Daniel J Urban; Vincent Setola; Brenda R S Temple; Bryan L Roth; Stefan Knapp; Francis S Willard; David P Siderovski
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

Review 5.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

6.  Nucleobindin 1 is a calcium-regulated guanine nucleotide dissociation inhibitor of G{alpha}i1.

Authors:  Neeraj Kapoor; Ruchi Gupta; Santosh T Menon; Ewa Folta-Stogniew; Daniel P Raleigh; Thomas P Sakmar
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

7.  Mx1-cre mediated Rgs12 conditional knockout mice exhibit increased bone mass phenotype.

Authors:  Shuying Yang; Yi-Ping Li; Tongjun Liu; Xiaoning He; Xue Yuan; Chunyi Li; Jay Cao; Yunjung Kim
Journal:  Genesis       Date:  2013-02-25       Impact factor: 2.487

8.  The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Galpha-interaction face.

Authors:  Adam J Kimple; Francis S Willard; Patrick M Giguère; Christopher A Johnston; Viorel Mocanu; David P Siderovski
Journal:  Biochim Biophys Acta       Date:  2007-06-29

9.  Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity.

Authors:  Thomas Zielinski; Adam J Kimple; Stephanie Q Hutsell; Mark D Koeff; David P Siderovski; Robert G Lowery
Journal:  J Biomol Screen       Date:  2009-12

Review 10.  Role of regulator of G protein signaling proteins in bone.

Authors:  David Keinan; Shuying Yang; Robert E Cohen; Xue Yuan; Tongjun Liu; Yi-Ping Li
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.